This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

LORENZ DrugTrack Solution: Take A Closer Look

Do you know the value of your data? drugTrack EVMPD works flawlessly as a stand-alone solution. Yet the software will yield significantly more added value when purchased as part of drugTrack PRO which will allow you to re-use your xEVMPD data for other important regulatory information tasks.

Manage your full regulatory lifecycle The system presents an opportunity for companies to manage all regulatory affairs information with a single system, saving both cost and time in the process. LORENZ drugTrack PRO can use a company's accumulated data to track the entire regulatory lifecycle on both the national and European levels, thus eliminating the time and cost of maintaining two parallel tracking systems.

Identify the impact of changes in your product composition In addition, drugTrack offers cost-saving features such as batch reporting. When a variation such as a change in a supplier address arises, drugTrack can generate a report of all registrations affected by the change, market by market, and generate the variation reports to all of the relevant national authorities.

Plan your regulatory strategy The entire drugTrack system was originally developed together with a pharmaceutical company to satisfy their regulatory tracking needs. It provides a level of security and complexity that the traditional range of spreadsheets, calendar entries and handwritten notes simply cannot. In that scenario, spreadsheet data can be changed accidentally with no control, multiple versions of the same sheet can circulate at the same time, and there is no consistent system for reminders and deadline alerts. drugTrack integrates all of this into a single database system where every step is tracked and remains transparent. Marked entries highlight where changes have been made between versions. And notifications and reminders ensure that no deadline is missed.

The LORENZ drugTrack system will also support the global ISO Identification of Medicinal Products (IDMP) format when it comes into force.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $92.69 -0.59%
FB $119.49 1.43%
GOOG $711.11 1.40%
TSLA $214.93 1.61%
YHOO $37.23 0.79%


Chart of I:DJI
DOW 17,740.63 +79.92 0.45%
S&P 500 2,057.14 +6.51 0.32%
NASDAQ 4,736.1550 +19.0610 0.40%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs